Browse studies

Find your next paid study

1 recruiting study matching your filters

A Pilot Study of a DNAJB1-PRKACA Fusion Kinase Peptide Vaccine Combined With Nivolumab and Ipilimumab for Patients With Fibrolamellar Hepatocellular Carcinoma

The primary objective of the trial is the safety and tolerability of administering a vaccine targeting the DNAJB1-PRKACA fusion kinase, in combination with niv…

Fibrolamellar Hepatocellular Carcinoma (FLC)

Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsNCT04248569